Stability indicating RP-HPLC method for simultaneous determination of guaifenesin and pseudoephedrine hydrochloride in the presence of syrup excepients  by Abdelwahab, Nada S. & Abdelaleem, Eglal A.
Arabian Journal of Chemistry (2013) xxx, xxx–xxxKing Saud University
Arabian Journal of Chemistry
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEStability indicating RP-HPLC method for simultaneous
determination of guaifenesin and pseudoephedrine
hydrochloride in the presence of syrup excepientsNada S. Abdelwahab, Eglal A. Abdelaleem *Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, Bani-Suef University, Alshaheed Shehata Ahmad
Hegazy St., 62514 Beni-Suef, EgyptReceived 13 October 2012; accepted 16 November 2013*
+
E
eg
Pe
18
ht
P
pKEYWORDS
RP-HPLC;
Guaifenesin;
Pseudoephedrine;
Guaiacol;
Stability indicating assay
method (SIAM)Corresponding author. Te
20 82 2317950.
-mail addresses: nadasayed
lal_bardisi@yahoo.com (E.A
er review under responsibilit
Production an
78-5352 ª 2013 King Saud U
tp://dx.doi.org/10.1016/j.arab
lease cite this article in press as:
seudoephedrine hydrochloride inl.: +20
2003@ya
. Abdela
y of King
d hostin
niversity
jc.2013.1
Abdelwah
the presenAbstract The present work concerns with the development of stability indicating the RP-HPLC
method for simultaneous determination of guaifenesin (GUF) and pseudoephedrine hydrochloride
(PSH) in the presence of guaifenesin related substance (Guaiacol). GUC, and in the presence of
syrup excepients with minimum sample pre-treatment. In the developed RP-HPLC method efﬁcient
chromatographic separation was achieved for GUF, PSH, GUC and syrup excepients using ODS
column as a stationary phase and methanol: water (50:50, v/v, pH = 4 with orthophosphoric acid)
as a mobile phase with a ﬂow rate of 1 mL min1 and UV detection at 210 nm. The chromato-
graphic run time was approximately 10 min. Calibration curves were drawn relating the integrated
area under peak to the corresponding concentrations of PSH, GUF and GUC in the range of 1–8,
1–20, 0.4–8 lg mL1, respectively. The developed method has been validated and met the require-
ments delineated by ICH guidelines with respect to linearity, accuracy, precision, speciﬁcity and
robustness. The validated method was successfully applied for determination of the studied drugs
in triaminic chest congestion syrup; moreover its results were statistically compared with those
obtained by the ofﬁcial method and no signiﬁcant difference was found between them.
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Pseudoephedrine HCl (PSH) is (1S,2S)-2-(methylamino)-1-
phenylpropan-1-ol hydrochloride (The British Pharmacopoeia,
2007). It is a stereoisomer of ephedrine and has similar action.
PSH and its salts are orally used for the symptomatic relief of
nasal congestion and are commonly used in combination with
other ingredients in preparations intended for the relief of
cough and cold symptoms (Martindale, 2005). Guaifenesin
(GUF) is (2RS)-3-(2-methoxyphenoxy)propane-1,2-diol (The
British Pharmacopoeia, 2007), it is reported to increase theier B.V. All rights reserved.
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Table 1 Comparison between sensitivity of some of the
reported methods and that of the developed RP-HPLC method.
The reported methods PSH Range
(lg mL1)
GUF Range
(lg mL1)
USP (2009) 100 100
Shuhan et al. (2005) 3–15 20–100
Xiaohui and Stewart (2000) 15–150 100–1000
Wilcox and Stewart (2000) 7.5–30 50–200
Rahul et al. (2011) 300–1500 30–150
Siavash et al. (2011) 5–30 5–33
The developed HPLC method 1–8 1–20
2 N.S. Abdelwahab, E.A. Abdelaleemvolume and reduce the viscosity of tenacious sputum and is used
as an expectorant for productive cough. Also it has been given
to patients with altered nasal mucociliary clearance associated
with HIV infection (Martindale, 2005). Guaiacol (GUC) is 2-
methoxyphenol (The British Pharmacopoeia, 2007), in BP and
USP (The British Pharmacopoeia, 2007; USP, 2009), it is con-
sidered as GUF impurity and related substance. Also it is re-
ported in USP (2009) that the GUF sample must be excluded
when Guaiacol and Guaifenesinb-isomer is detected.
The literature survey revealed that some techniques have
been published for the determination of PSH and GUF either
in their combined form or in combinations with other drugs.
RP-HPLC methods have been used for the determination of
PSH and GUF in their ternary mixture with dextromethorphan
hydrogen bromide (USP, 2009; Shuhan et al., 2005; Yongqing
et al., 2000; Xiaohui and Stewart, 2000; Leroy et al., 1998; Sher-
vington, 1997; Louhaichi et al., 2009). Moreover, combinations
of the studied drugs with other cough and cold medicines have
been analyzed by different RP-HPLC (Louhaichi et al., 2009;
Lei and Nan, 2004; Histochi et al., 2005; Vaidya et al., 2001;
Wilcox and Stewart, 2000) and GC (Thresiana et al., 2005)
methods. On the other hand, USP (2009) determined PSH
andGU binary mixtures by a RP-HPLCmethod but with using
two mobile phases. Also, PSH and GUF combination has been
determined by different spectrophotometric methods such as
simultaneous equation (Rahul et al., 2011), Q-analysis spectro-
photometry (Rahul et al., 2011) and multivariate calibration
method (Siavash et al., 2011).
Due to the low sensitivity, Table 1, and selectivity of the re-
ported methods and also due to the importance of detection of
the lowest concentration of GUC in GUF samples (USP,
2009), our target was to develop and validate a sensitive, selec-
tive and simple stability indicating RP-HPLC method for the
determination of PSH, GUF and GUC with good accuracy
and precision without interference from syrup excepients.
The developed method has an advantage of using a single mo-
bile phase with a simple composition for good chromato-
graphic separation of all the studied components and
excepients within short analysis time.
2. Experimental
2.1. Samples
2.1.1. Pure standards
Pure PSH and GUF samples with claimed purity of 98.5% and
99.0%, respectively according to the manufacturer’s certiﬁcate
were kindly supplied by Novartis Pharma S.A.E Cairo, Egypt.Please cite this article in press as: Abdelwahab, N.S., Abdelaleem, E.A. Stability in
pseudoephedrine hydrochloride in the presence of syrup excepients. Arabian JournaPure GUC sample with claimed purity of 99.3% was pur-
chased from Sigma–Aldrich Co., Cairo, Egypt.
2.1.2. Pharmaceutical formulation
Triaminic chest congestion syrupbatch No. Y0005, labeled
to contain 15 mg PSH and 50 mg GUF per 5 mL syrup, man-
ufactured by NOVARTIS PHARMA S. A. E Cairo, EGYPT
under license from Novartis Consumer Health Switzerland
and its afﬁliate in USA.
2.2. Chemicals and solvents
Methanol and orthophosphoric acid were of HPLC grade (Sig-
ma–Aldrich Chemie GmbH, Germany), de-ionized water was
from SEDICO Pharmaceuticals Co., Egypt.
2.3. Solutions
Stock standard solutions of PSH, GUF and GUC were prepared
in methanol in the concentration of 1 mg mL1 by accurately
weighting 0.1 g each of PSH, GUF and GUC into three sepa-
rate 100-mL volumetric ﬂasks, dissolving in and diluting to the
volume with methanol.
Working standard solutions of PSH, GUf and GUC
were prepared in methanol in the concentration of
0.1 mg mL1 by transferring 10 mL each of PSH, GUF and
GUC stock standard solutions into three separate 100-mL
volumetric ﬂasks and completing to the volume with
methanol.
Pharmaceutical formulation solution: 5 mL of triaminic
chest congestion syrup was accurately transferred (after vig-
orous shaking) into a 50 mL measuring ﬂask, sonicated in
25 mL methanol for 5 min and the volume was then made
up to the mark with methanol in order to prepare the stock
solution (1 mg mL1) of GUF and the corresponding concen-
tration of PSH from which sample working solution
(0.1 mg mL1 GUF) was prepared.
2.4. Instruments
HPLC (Shimadzu, Japan) instrument was equipped with a
model series LC-10 ADVP pump, SCL-10 AVP controller,
DGU-12 A degasser and SPD-10 AVP UV–VIS detector. Sep-
aration and quantitation were made at room temperature on a
250 mm · 4.6 mm (i.d.) Hidrosorb RP- C18 column (5 lm par-
ticle size) purchased from Merck (Dalmstaad, Germany). The
detector was set at 210 nm.
3. Procedure
3.1. Chromatographic conditions
Chromatographic separation was carried out using isocratic
elution and de ionized water: methanol (50:50, by volume
pH 4 with orthophosphoric acid) as a mobile phase delivered
at a ﬂow rate 1 mL min1. Injection volume was 20 lL and
detection has been carried out at 210 nm at room temperature.
The run time was 10 min and the total peak height was used to
quantify each of the studied components.dicating RP-HPLC method for simultaneous determination of guaifenesin and
l of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.019
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Accurate aliquots in the range of 1–8, 1–20 and 0.4–8 lg mL1
each of PSH, GUF and GUC, respectively were separately pre-
pared from their respective working standard solutions
(100 lg mL1) in the mobile phase into three separate series
of 10-mL volumetric ﬂasks. Triplicate injections were made
for each concentration; the peak height was used to construct
the calibration curve for each component from which its
regression equation was constructed.
3.3. Application to pharmaceutical formulation
Different concentrations (2.4, 3 and 6 lg mL1 PSH, 8, 10 and
20 lg mL1 GUF) were prepared from the previously prepared
pharmaceutical formulation working solution (0.1 mg mL1)
and the procedure mentioned under linearity and construction
of calibration curves was followed. Concentrations of PSH and
GUF have been calculated from their respective regression
equations and the percentage recoveries were then calculated.
3.4. Recovery studies
Recovery studies were carried out by applying the developed
method to the drug sample to which known amounts of pure
PSH and GUF corresponding to 80%, 100% and 120% (of
concentration 3 lg mL1 PSH and 8 lg mL1 GUF) were
added. At each level three determinations were performed
and the percentage recoveries of the added pure drugs were
calculated.Figure 1A RP-HPLC chromatogram of a resolved mixture of standa
(C) (Rt = 9.24 min) using de ionized water: methanol (50:50, v/v pH=
Please cite this article in press as: Abdelwahab, N.S., Abdelaleem, E.A. Stability in
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HPLC has become a widely used tool for the routine analysis
and separation of drugs in pure form or in pharmaceutical for-
mulations (Rao et al., 2010) either alone or in the presence of
degradation products and excepients (Patel and Rao, 2011;
Moussa et al., 2011; Hassib et al., 2011).
In USP (2009) GUC is reported to be GUF impurity and
related substance which should be absent in the accepted
GUF sample. All the reported methods concerned with the
analysis of GUF and PSH without taking into consideration
the presence of GUC or syrup excipients. Hence the aim of this
work was to develop selective stability indicating RP- HPLC
method for good chromatographic separation of the studied
drugs from syrup excepients and to determine the lowest
amounts of GUF impurity.
4.1. Method development and optimization
The ﬁrst step in method development is to test all the published
RP-HPLC mobile phases. None of these mobile phases was
able to achieve good resolution among GUF, PSH, GUC
and syrup excepients. Different parameters were manipulated
to obtain an acceptable resolution between the three studied
components and syrup excepients, reduce the analysis time, en-
hance LOD and LOQ of the method and to satisfy HPLC sys-
tem suitability parameters.
The chromatographic separation was started with ODS col-
umn as a stationary phase and acetonitrile: de ionized H2O
with different ratios (30:70–70:30 v/v) as a mobile phaserd PSH (A) (Rt = 4.48 min), GUF (B) (Rt = 7.34 min) and GUC
4 with phosphoric acid).
dicating RP-HPLC method for simultaneous determination of guaifenesin and
l of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.11.019
4 N.S. Abdelwahab, E.A. Abdelaleemmaintaining the ﬂow rate at 1 mL min1, where bad resolution
among the studied components was obtained. Replacing aceto-
nitrile with methanol in the mobile phase slightly enhanced the
resolution and the ratio (50:50 v/v) gave the best resolution
among GUF, PSH and GUC but with bad resolution between
GUF and syrup excepients. Different pH values (3–6) were
tested where pH= 4 gave the best chromatographic resolution
between PSH, GUF, GUC and excepients. On the other hand,
different scanning wavelengths were tried (210, 225, 278 and
254 nm) in order to enhance the sensitivity of the method
where scanning at 210 nm gave considerable sensitivity for
all the studied components.
After method optimization, the chromatographic separation
has been carried out using ODS column (250 mm · 4.6 mm,Table 2 Regression and analytical parameters of the pro-
posed RP-HPLC for the determination of Pseudoephedrine
HCl, Guaifenesin and Guaiacol.
Parameters PSH GUF GUC
Calibration range 1–8 lg mL1 1–20 lg mL1 0.4–8 lg mL1
Slope 0.7151 0.6063 1.3595
Intercept 0.1461 0.0803 0.2753
Correlation coeﬃcient 0.9996 0.9997 0.9995
Accuracy 99.42 99.81 101.20
Precision
Repeatability 0.966 1.662 0.957
Intermediate precision 1.466 0.928 1.137
LOD 0.30 lg mL1 0.20 lg mL1 0.10 lg mL1
LOQ 1 lg mL1 1 lg mL1 0.4 lg mL1
Figure 1B RP-HPLC chromatogram of Triaminic chest congesti
(Rt = 6.7 min) and GUF (C) (Rt = 7.34 min) using de ionized water:
Please cite this article in press as: Abdelwahab, N.S., Abdelaleem, E.A. Stability in
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water (50:50 v/v, pH = 4 with orthophosphoric acid), ﬂow rate
of 1 mL min1 and UV detection at 210 nm for all components.
Typical HPLC chromatograms, Fig. 1A, showed good separa-
tion between PSH (4.48 min), excepients (6.7 min), GUF
(7.34 min) and GUC (9.24 min).
4.2. Methods validation
ICH guidelines (ICH, 2005) for analytical method validation
have been followed during method validation.
4.2.1. Linearity
Under optimum chromatographic conditions, linear relation-
ships were obtained between the mean integrated peaks height
and the corresponding concentrations for each of PSH, GUF
and GUC in the ranges of 1–8, 1–20 and 0.4–8 lg mL1,
respectively. The evaluation parameters like slope, intercept
and the correlation coefﬁcients were calculated and presented
in Table 2.
4.2.2. Accuracy
Accuracy was calculated as the percentage recoveries of blind
pure PSH, GUF and GUC, it was further assured by perform-
ing recovery studies at three levels (80%, 100% and 120%
addition) and the average percent recovery was then calcu-
lated. Good percentage recoveries were obtained as shown in
Table 2.
4.2.3. Precision
It was studied with respect to both repeatability and interme-
diate precision. Repeatability was calculated by the analysison syrup containing PSH (A) (Rt = 4.48 min), excepient (B)
methanol (50:50, v/v pH = 4 with phosphoric acid).
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Table 4 System suitability testing parameters of the devel-
oped RP-HPLC method.
GUCGUFExcepientPSHParameters
9.24 min7.34 min6.7 min4.48 minRt
1  1.071.061  Peak a 
symmetry
2.4 13.7Resolution (Rs)
3.32.412.121.08Capacity factor (k')
1.371.141.96Selectivity (α)
RP-HPLC for simultaneous determination of guaifenesin and pseudoephedrine hydrochloride 5of three different concentrations of pure components (3, 5
and 7 lg mL1 for PSH and GUC), (4, 10 and 15 lg mL1
for GUF) in triplicate on the same day. The experiment
was repeated on the same concentrations seven times on
four consecutive days to determine the intermediate precision.
Good results and acceptable RSD%, Table 2, were
obtained.
4.2.4. Speciﬁcity
Speciﬁcity of the method was tested by how accurately and
speciﬁcally the analytes of interest are determined in the pres-
ence of other components (impurities, degradates or excepi-
ents) (US FDA, 2000). It was veriﬁed from the HPLC
chromatogram, Fig. 1B. Furthermore, good results obtained
on applying the method to triaminic chest congestion syrup,
Table 3 proved that syrup additives did not interfere with any
of the three separated components.
4.2.5. Limits of detection and quantitation (LOD and LOQ)
ICH recommendations (ICH, 2005) using visual non instru-
mental method were followed to calculate the values of LOD
and LOQ. The low values of LOD and LOQ indicate the high
sensitivity of method, Table 2.
4.2.6. Robustness
Deliberate small changes in the method parameters (e.g.
changing in% methanol in the mobile phase ±1%, changing
in mobile phase pH± 0.2, changing in ﬂow
rate ± 0.05 mL min1 and change in scanning wave-Table 3 Determination of the studied drugs in triaminic chest
congestion
syrup by the proposed RP-HPLC method and statistical
comparison with the reported RP-HPLC method.
Pharmaceutical formulation PSH
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% Recovery a
98.36±1.402 
Standard Addition Technique b
Pure added ( µg mL-1) Found ( µg mL-1) % Recovery 
2.40 2.36 98.33 
3.00 3.03 101 
3.60 3.57 99.17 
Mean ± RSD% 99.50±1.372 
F-test (5.050) c
1.437
Student's –t test (2.228 ) c
1.612
GUF
% Recovery a
96.66±1.505 
Standard Addition Technique b
Pure added (µg mL-1) Found ( µg mL-1) % Recovery 
6.40 6.51 101.72 
8.00 7.94 99.25 
9.60 9.68 100.83 
Mean+ RSD% 100.60± 1.244 
F-test (5.050) c
1.133
Student's –t test (2.228 ) c
1.976
aAverage of 6 determinations.
bAverage of 3 determinations.
cThe values in the parenthesis are the corresponding theoretical
values at p = 0.05.
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peak height or symmetry of the peaks.
4.2.7. System suitability
System suitability parameters were carried out to prove that
the overall system performed well, it was checked by calculat-
ing different parameters, e.g. capacity, selectivity, resolution
and peak asymmetry. The obtained values were in the accept-
able ranges as shown in Table 4.
4.3. Application of the method
After method optimization and validation, the developed RP-
HPLC method has been successfully applied for the determina-
tion of PSH, and GUF in triaminic chest congestion syrup.
The agreement between the obtained results and the labeled
amounts conﬁrmed the speciﬁcity of the developed method,
Table 3. The accuracy of the method was further assessed by
application of standard addition technique where good results
were obtained and given in Table 3.
The results of the developed method were statistically com-
pared with those obtained by the reported.
RP-HPLC method (USP, 2009) at 95% conﬁdence level
using the student’s t test and variance ratio F-test. No
signiﬁcant difference was found between the two methods,
Table 3.
5. Conclusion
The present work concerns with the development and validation
of stability indicating the RP-HPLC method for the simulta-
neous determination of PSH, GUF and GUC without sample
pretreatment and without interference from syrup excepients.
The developed method has an advantage over any reported
method in being able to determine the studied drug along with
GUF impurity with high sensitivity, selectivity and short analy-
sis time using the isocratic mobile phase for all components.
Moreover, it has been successfully applied to triaminic chest
congestion syrup and no interference from excepients has been
found. The developed method can be easily applied for quality
analysis of the studied drugs.
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